Pricing Log in Create free account
Friday 6 November 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

KRYS Healthcare Biotechnology

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024.

Revenue
+30.2%
EPS
−22.3%
Free cash flow
+137.8%

Quarter to September 2026, against a year earlier

301.84 1.59 +0.53%
Market cap
$8.9B
P/E
39.2×
Fwd P/E
45.7×
Dividend yield
—
F-score
7/9
Altman Z
39.03
Beneish M
−2.27
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Krystal Biotech, Inc. (KRYS) Book value per share

Alert me on Book value per share

Krystal Biotech, Inc.'s book value per share at the end of fiscal 2025 was 42.1×, up 27.3% from 33.1× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 48.5×. Over the past ten years it has ranged from 0.3× (fiscal 2016) to 42.1× (fiscal 2025) — the current reading is the highest in ten years. Krystal Biotech, Inc. ranks 13th of 611 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 42.1× 27.30%
FY2024 33.1× 15.43%
FY2023 28.7× 39.97%
FY2022 20.5× (23.39%)
FY2021 26.7× 72.00%
FY2020 15.5× 21.83%
FY2019 12.8× 26.26%
FY2018 10.1× 9.52%
FY2017 9.2× 2,702.46%
FY2016 0.3× —

Quarterly newest first

Period Book value per share Change
Sep 2026 48.5× 5.34%
Jun 2026 46.0× 5.58%
Mar 2026 43.6× 3.46%
Dec 2025 42.1× 7.21%
36 more quarters

Against its own ten years

Low 0.3× High 42.1×
Ten-year median 18.0×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
KRYS Krystal Biotech, Inc. 48.5×
MDGL Madrigal Pharmaceuticals, Inc. compare 21.4×
PTGX Protagonist Therapeutics, Inc. compare 12.8×
SYRE Spyre Therapeutics, Inc. compare 11.9×
TWST Twist Bioscience Corporation compare 7.1×
TGTX TG Therapeutics, Inc. compare 4.3×
CYTK Cytokinetics, Incorporated compare 0.0×
CAI Caris Life Sciences,�Inc. compare 0.0×
IBRX ImmunityBio, Inc. compare −1.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on KRYS